Mindray - Pulse Oximeter - PM60
Non Technical and Terms
- Initial Delivery Time - varies by country
- Pricing Incoterm - CIP
- Warranty - 18 months
- Note: Cost of installation, training and 18 months after sales service provided with CIP pricing
West Asia: Afghanistan, Bhutan, Nepal, Pakistan and Sri Lanka,.
Latin America And Pacific: Bolivia, Ecuador, El Salvador. Fiji, Guatemala, Haiti, Honduras, Marshall Islands, Panama, Papua New Guinea, Paraguay, Samoa, Uruguay
Supplier shall provide in-person or on-line training adequate to meet the needs of all operators. Training shall be available in English, Spanish and French, and shall be available to users within two (2) weeks of equipment delivery. (Cost of training quoted on when a Registration of Interest is received).
User Manuals: Supplier shall provide at least one (1) user manual for each device purchased. Manuals shall provide guidance on the operation of all features of the purchased device, be provided in at a printed format, and be available in English, Spanish and French.
Service Manuals: Supplier shall provide at least one (1) service manual for each device purchased. Manuals shall provide at least, equipment schematics, parts summaries, preventive maintenance requirements, and troubleshooting guidance, be accessible in printed formats, and be available in English.
Mindray (www.mindray.com) is a global provider of medical devices and solutions including patient monitoring and life support, invitro diagnostics, and medical imaging equipment. Mindray has one of the largest medical device manufacturing facilities in China.
Pulse oximeters are used to noninvasively measure saturated hemoglobin in tissue capillaries. These devices are comprised of the pulse oximeter and a sensor/probe that may designed to adhere to the patient’s finger (most common option), toe, forehead, or ear. The probe contains light emitting diodes (LEDs) that emit red and infrared lights that pass through the arteries and feeds information back to a microprocessor.
Pulse oximeters measure oxygenated and deoxygenated hemoglobin using these lights to read changing absorbance in hemoglobin due to pulsating blood flow in the arteries. This process allows for monitoring of oxygenated hemoglobin versus deoxygenated hemoglobin (not measured through light), which is revealed as an oxygenation percentage (i.e., 70% to 100%). Through this process, pulse oximeters allow for accurate monitoring of pulse rate and oxygenation percentage while providing a means of rapid detection of hypoxia, or decreased saturated oxygen rates, before onset of pathological injury and clinical symptoms.
Additionally, this information helps clinicians assess the amount of oxygen being carried in the blood and evaluate the need for supplemental oxygen.
Pulse Oximeter sensors
ECRI recommends using a higher ratio of adhesive sensors to minimize the burden and risk from cleaning and disinfecting reusable sensors between COVID-19 patient uses.
When estimating adhesive sensor quantities, ECRI recommends planning for five adhesive sensors per week per device, which is an increase from a normal condition estimates of four sensors per week. Adhesive sensors are intended for single patient use only.
For reusable sensors, ECRI recommends purchasing 12 sensors per device.